Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension

Exclusion Criteria

• •Known secondary hypertension patients
• •Patients who have renal artery which is not adequate for renal denervation
• •1. The main renal artery diameter \< 4 mm, or renal artery length \< 20 mm
• •2. The renal arteries into which stable catheter insertion is difficulty and which have hemodynamically or anatomically significant stenosis
• •3. The renal arteries who have undergone renal angioplasty
• •Patients who have history of myocardial infarction, unstable angina, syncope cerebrovascular insufficiency or extensive atherosclerotic disease with intravascular thrombosis, or unstable plaque
• •Type 1 Diabetes
• •Patients who have scheduled percutaneous coronary intervention (PCI) or operation within 6 months
• •Hemodynamically significant valvular heart disease in which blood pressure reduction may cause significant deterioration of patient's health.
• •Primary pulmonary hypertension
• •Patients who have the intracardiac defibrillator(ICD) or pacemaker which do not allow delivery of radiofrequency energy.
• •Patients who require continuous oxygen supply or mechanical ventilation for treatment of obstructive sleep apnea
• •Patients who have serious medical condition which can compromise the safety of the patients and the safety and integrity of the study.
• •Patients who have unresolved drug issue, alcoholism
• •Patients who lack ability to understand and follow the instruction the researcher
• •Patient who cannot follow up
• •Patients who are registered in other trial
• •Patients who are pregnant, nursing or planning to be pregnant